Rollover Study for Continuing NBI-98854 Administration in Pediatric Subjects With Tourette Syndrome
Clinical trial NCT03732534 · TERMINATED
Trial details
- NCT number
- NCT03732534
- Sponsor
- Neurocrine Biosciences
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-17
- Primary completion
- 2019-02-18
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.